Table 2.
All, n (%) n = 122 | Red Zoneb, n (%) n = 39 (32) | North, n (%) n = 26 (21) | Centre, n (%) n = 18 (15) | South and islands, n (%) n = 25 (20) | ||
---|---|---|---|---|---|---|
Vaccination of oncologic pts in view of a systemic therapy | No | 8 (7) | 2 (5) | 2 (8) | 2 (11) | 0 |
Yes | 114 (93) | 37 (95) | 24 (92) | 16 (89) | 25 (100) | |
Which kind of oncologic treatment will the vaccinated pts receivea | CT | 28 (25) | 8 (20) | 7 (27) | 4 (22) | 6 (24) |
ICI | 12 (11) | 4 (10) | 4 (15) | 1 (5) | 1 (4) | |
HT, TT | 16 (14) | 6 (15) | 4 (15) | 2 (11) | 3 (12) | |
None, follow-up | 8 (7) | 3 (8) | 1 (4) | 0 | 2 (8) | |
All pts | 64 (57) | 22 (56) | 16 (61) | 5 (28) | 16 (64) | |
Pts with risk factorsc | 42 (37) | 14 (36) | 7 (27) | 8 (44) | 7 (28) | |
Which kind of vaccination is/are adviseda | Seasonal flu | 72 (64) | 27 (69) | 17 (65) | 11 (61) | 12 (48) |
Pneumococcal | 8 (7) | 3 (8) | 2 (8) | 0 | 0 | |
Both | 42 (37) | 11 (28) | 8 (31) | 4 (22) | 13 (52) | |
Other (tetanus, VZV) | 1 (<1) | 1 (<1) | 0 | 0 | 0 | |
Report of seasonal flu cases (e.g. national registry) | No | 94 (80) | 28 (72) | 21 (81) | 16 (89) | 23 (92) |
Yes | 15 (13) | 8 (20) | 3 (11) | 1 (5) | 2 (8) | |
UNK | 9 (7) | 3 (8) | 2 (8) | 1 (5) | 0 |
BMI, body mass index; CT, chemotherapy; HT, hormonal therapy; ICI, immune-checkpoint inhibitors; pts, patients; TT, targeted therapy; UNK, unknown; VZV, varicella zoster virus; COVID-19, novel coronavirus disease.
Questions with more than one possible answer.
Red Zone at the time of the survey includes the following Italian countries: Lombardia, Emilia Romagna, Veneto.
Age ≥75 years, cardiovascular and/or respiratory disease, chronic infections, diabetes, obesity (BMI ≥ 30), immune-suppressive therapies.